Pseudomonas aeruginosa and cyanide production

Lenney W., Gilchrist F.J.

Source: Eur Respir J 2011; 37: 482-483
Journal Issue: March
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lenney W., Gilchrist F.J.. Pseudomonas aeruginosa and cyanide production. Eur Respir J 2011; 37: 482-483

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011



Exposure to particulate matter increases pyocyanin production in Pseudomonas aeruginosa
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017

Mechanisms of induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin
Source: Eur Respir J 2004; 24: Suppl. 48, 107s
Year: 2004

Dental units as infection sources of Pseudomonas aeruginosa
Source: Eur Respir J 2008; 32: 1122-1123
Year: 2008


Non-invasive detection of Pseudomonas aeruginosa
Source: Eur Respir J 2005; 26: Suppl. 49, 640s
Year: 2005

Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017


Pseudomonas aerugenosa sensitivity changes to antibiotics under the influence of dissolved ozone
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Host response to transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2004; 23: 493-494
Year: 2004


The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003



In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Pseudomonas aeruginosa and legionella pneumophilia in water of dental units
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006

Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018

Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in vivo
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021

Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011

Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?
Source: Eur Respir J 2011; 38: 1483-1486
Year: 2011


Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003

Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018


Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017